TNF and osteosarcoma: Human osteosarcoma xenografts grew somewhat slower in SCID mice treated with LCL161 than in untreated mice [55], although TNFα levels may be lower in SCID mice than wild type animals [56], so that study may have underestimated the ability of LCL161 to cooperate with host-derived TNFα to kill implanted tumor cells.